Alvotech and Advanz Pharma Receive UK Marketing Authorisations for Gobivaz®

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

November 07, 2025 | Friday | News
Santhera Closes USD 13 Million Royalty Monetization Agreement to Support AGAMREE® Global Launches

 Santhera Pharmaceuticals (SIX: SANN) announces the closing of a USD 13 million royalty monetization agreement, first announced in September 2025, t...

November 06, 2025 | Thursday | News
Clearmind Medicine Files Patent in South Korea for MEAI in Depression Treatment

Patent expands MEAI’s global intellectual property protection as Clearmind advances clinical development and commercialization plans Clearmind Med...

November 06, 2025 | Thursday | News
Jupiter Neurosciences Receives FDA IND Clearance to Initiate Phase 2a Trial of JOTROL™ in Parkinson’s Disease

Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based therapeutic pla...

November 06, 2025 | Thursday | News
Eli Lilly to Invest $3 Billion in New European Manufacturing Facility at Leiden Bio Science Park, Netherlands

Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain Eli Lilly and Company ...

November 04, 2025 | Tuesday | News
ChemDiv Expands Partnership to Advance Ratutrelvir, a Rationally Designed Ritonavir-Free Mpro Inhibitor for COVID-19

ChemDiv, a global provider of integrated drug discovery solutions,  announced the extension of its Chemistry, Manufacturing and Controls (CMC) servi...

October 31, 2025 | Friday | News
N2OFF Completes Merger with MitoCareX Bio to Expand into Cancer Drug Discovery Targeting Mitochondrial Proteins

N2OFF, Inc. a cleantech company investing in solar energy assets based on the RTB (Ready to Build) business model, recently announced the closing of the ...

October 31, 2025 | Friday | News
Thermo Fisher Scientific to Acquire Clario for $8.9 Billion to Accelerate Digital Transformation of Clinical Research

Expected to be immediately accretive to Adjusted Earnings Per Share (EPS)¹ after close Attractive return profile given high growth and strong margi...

October 30, 2025 | Thursday | News
Samsung Bioepis to Assume Full Commercial Control of BYOOVIZ in Europe by January 2026

  Samsung Bioepis will assume full commercial responsibility for BYOOVIZ®(ranibizumab) upon full transition of Biogen’s commercializa...

October 30, 2025 | Thursday | News
Zag Bio Launches with $80 Million Financing to Pioneer Thymus-Targeted Therapies for Autoimmune Diseases

Discovery and development of the first systemic therapeutics to deliver self-antigens directly to the thymus to harness the body’s natural mechanis...

October 29, 2025 | Wednesday | News
GSK and Empirico Enter Exclusive Licensing Agreement for Novel siRNA Candidate EMP-012 in COPD

siRNA candidate EMP-012 in phase I for treatment of COPD EMP-012 targets a distinct inflammatory pathway with enhanced potency and longer dose int...

October 29, 2025 | Wednesday | News
Catalent Introduces New Corporate Brand to Champion “Missions That Matter” Across Global Healthcare

Reflects Catalent’s unparalleled service and best-in-class capabilities across the pharmaceutical, biotech and consumer health categories Rein...

October 29, 2025 | Wednesday | News
BD Showcases Next-Generation Drug Delivery and RFID Traceability Solutions at CPhI 2025

 BD (Becton, Dickinson and Company), a leading medical technology company, will feature the next generation of drug delivery and traceability s...

October 28, 2025 | Tuesday | News
Thermo Fisher Scientific Showcases Next-Generation Biopharma Solutions and AI-Driven Innovations at CPHI Frankfurt 2025

Company highlights its global expertise and new and expanded capabilities to help biopharma and biotech customers solve global health challenges Thermo ...

October 28, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close